Mark Chin - 23 Jun 2021 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Mark Chin
Issuer symbol
ITRM
Transactions as of
23 Jun 2021
Transactions value $
$0
Form type
4
Filing time
25 Jun 2021, 16:06:36 UTC
Previous filing
14 May 2021
Next filing
30 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Stock Units Award $0 +36,798 $0 36,798 23 Jun 2021 Ordinary Shares 36,798 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
F2 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended, the RSUs shall vest in full on June 23, 2022.